News
-
ASGCT 2026 Day 3: PackGene Presents Upstream Strategies to Improve AAV Yield and Quality
May 14 2026 -
ASGCT 2026 Day 2: PackGene Highlights AAV Process Optimization and Continued Industry Engagement
May 13 2026 -
ASGCT 2026 Day 1: PackGene Showcases Advances in AAV Manufacturing and Analytical Innovation
May 12 2026 -
PackGene to Present Advances in Scalable AAV Manufacturing, Analytical Innovation, and Novel Capsid Engineering at ASGCT 2026
May 04 2026 -
PackGene to Offer Barcoded High-Throughput AAV Capsid Screening Kits Through Strategic License Agreement with Children’s Medical Research Institute
Aug 26 2025 -
SineuGene’s SNUG01 AAV Gene Therapy Granted FDA Orphan Drug Designation for ALS
Jun 26 2025 -
Genevector’s JWK002 AAV Gene Therapy for X-Linked Retinoschisis Receives NMPA IND Approval
Jun 25 2025 -
PackGene Supports NeueXcell Therapeutics’ NXL-001 Alzheimer’s Gene Therapy Clinical Milestone
Jun 12 2025 -
Starrygene’s AAV Bispecific Antibody Gene Therapy for wAMD Advances to Phase II with Support from PackGene
May 25 2025